About Us
About Carna
Management
Our Business
Products & Services
Products
Kinase Proteins and Other Protein Products
Assay Kits
Services
Activity-based Biochemical Screening/Profiling Assay Services
Cell-based Assay Services
Pricing & Technical Inquiry
Drug Discovery
Pipeline
Science
Technology
Partnering
Investors
News
Financial Reports/Presentations
Financial Highlights
IR Schedule
IR Contact
JP
EN
JP
EN
Kinase Inhibitor Discovery
with an untiring quest for future therapeutics
Our Business
Products & Services
Drug Discovery
Latest News
Mar 12, 2024
Investors
Carna Biosciences to present new preclinical data on monzosertib at AACR Annual Meeting
Feb 09, 2024
Investors
Corporate Presentation Feb. 2024
Feb 09, 2024
Investors
FY2023 Presentation
Feb 09, 2024
Investors
Consolidated Financial Results for the Year Ended December 31, 2023
Feb 07, 2024
Investors
Carna Biosciences and Carterra Jointly Present at SLAS2024
Dec 14, 2023
Investors
Revision of Results Forecast for the Fiscal Year Ending December 31, 2023
Dec 14, 2023
Investors
Carna Receives Second Milestone Payment from Gilead
Dec 11, 2023
Investors
Carna announces a poster presentation on design of ongoing Phase 1b study for its non-covalent BTK inhibitor AS-1763 at American Society of Hematology Annual Meeting
About Us
Investors
Investor Contact
Products & Services Contact